Three Competing Hemp Bills That Will Decide the Industry’s Future
Right now, Congress is considering three very different hemp bills: one that would completely undo Section 781 and the federal “hemp THC ban,” one that would delay its impact with a two‑year moratorium, and one that creates a tough regulatory framework that still wipes out most intoxicating hemp products. The outcome will determine whether hemp remains a viable industry for farmers, brands, and retailers, or becomes a niche footnote.
Quick Primer: What Section 781 Did
Section 781 of the 2025 federal spending bill quietly rewrote the definition of hemp and created strict federal caps on THC and “THC‑like” cannabinoids in finished consumer products. Instead of only counting delta‑9 THC in raw plant material, the new language uses a “total THC” standard and sets a very low per‑container limit that many edibles, vapes, beverages, and high‑THCA products cannot meet.
Industry groups and legal analysts agree that, if fully implemented as written, Section 781 would effectively ban most intoxicating hemp products nationwide while leaving states to figure out the messy enforcement details. That is why the current three‑bill fight matters so much: each bill offers a different way to respond to Section 781’s fallout.
Bill #1: Full Repeal of Section 781
The first approach is simple: delete Section 781 and restore the prior hemp framework. H.R. 6209, the “American Hemp Act of 2025,” is the clearest example; it amends the law to repeal Section 781 of the Continuing Appropriations Act and returns to the original 2018 Farm Bill definition of hemp.
Repeal would:
Remove the ultra‑low per‑container THC caps that capture most current intoxicating hemp SKUs.
Eliminate the new “total THC” and THC‑analog language that sweeps in THCA and many hemp‑derived cannabinoids.
Re‑open space for states to regulate hemp‑derived products under the more flexible 2018 Farm Bill framework instead of a de‑facto federal ban.
Repeal bills are strongly supported by national hemp trade groups and many farm‑state lawmakers who argue that Congress moved too fast and overreached in a must‑pass spending bill. For businesses that have built product lines around hemp‑derived cannabinoids, this is the only clean reset on the table.
Bill #2: Two‑Year Moratorium on the Ban
The second category of bills accepts that Section 781 exists but tries to push its impact further into the future. Representative Jim Baird and a bipartisan group of senators have introduced measures to extend Section 781’s “grace period” from one year to three, effectively turning it into a two‑year moratorium on enforcement.
Extending the timeline would:
Keep most intoxicating hemp products legal at the federal level until approximately late 2028 instead of late 2026.
Give farmers time to adjust crop plans and contracts rather than facing abrupt rule changes between growing seasons.
Allow Congress, agencies, and stakeholders to negotiate a more comprehensive replacement framework instead of relying on hurried appropriations language.
But the moratorium does not fix the underlying problem: Section 781’s structure and caps remain in the law, just delayed. For businesses, that means more runway but no long‑term certainty unless repeal or a better replacement passes later.
Bill #3: “Comprehensive Regulation” That Still Guts the Market
The third legislative path embraces the idea that intoxicating hemp products must be tightly controlled and builds a more detailed regulatory scheme on top of Section 781’s basic framework. These proposals often talk about “closing loopholes” and “protecting youth,” but they keep the core elements that make the current hemp market untenable.
Under this model, Congress would:
Lock in a total‑THC approach that counts delta‑9, THCA, and similar cannabinoids together and maintains very low per‑container caps.
Direct FDA and other agencies to catalog cannabinoids and draw bright lines between naturally occurring compounds and synthesized or converted ones, excluding many “hemp‑derived” intoxicants from the hemp category.
Treat products over the cap or made from listed synthetic cannabinoids as controlled substances, regardless of how they are marketed today.
In practice, that means most delta‑8, delta‑10, HHC, THCA flower, and high‑potency edibles would still disappear from the legal hemp space even though the language is framed as “regulation” rather than an explicit ban.
Stakeholders: Who Wins and Who Loses Under Each Bill?
Different players in the hemp ecosystem have very different stakes in which bill advances.
Farmers: Repeal offers the most stability and upside for diversified hemp crops, while a moratorium buys time but leaves long‑term demand uncertain; strict regulation could shrink viable acreage to niche, low‑THC fiber and grain.
Brands & retailers: Repeal preserves the broadest product mix; a moratorium allows for orderly pivot and inventory planning; strict regulation forces a massive shift toward non‑intoxicating or state‑licensed cannabis channels.
Consumers: Repeal keeps access to current hemp options with state‑level controls; a moratorium risks confusion and “now legal, later banned” whiplash; strict regulation cuts off many products, pushing some demand into unregulated gray or illicit markets.
For all three groups, the common thread is uncertainty: until Congress picks a lane, it is difficult to plan crops, product development, or long‑term investments.
Why Financial Infrastructure Matters in a Moving Target Environment
Financial services are already a pain point for hemp, CBD, and cannabis‑adjacent businesses, and these bills increase the risk of sudden account closures or derisking by traditional banks. When regulators and card networks are unsure what will be considered hemp vs. controlled substances in two years, “high‑risk” merchants are often the first to feel the squeeze.
That is exactly the gap Green Financial Service is designed to fill. The company specializes in nearly 100% approval rates for high‑risk merchant accounts, plus unsecured lines of credit, receivables‑based funding, and other capital tools for industries like CBD, THCA, smoke shops, kratom, and licensed cannabis. By pairing payments and funding, Green Financial helps operators stay liquid and keep accepting cards while they pivot product lines, adjust inventory, or diversify into new categories.
Take Action: Use Green Advocacy to Contact Your Lawmakers
Policy is not happening in a vacuum, members of Congress are hearing from attorneys general, regulators, and anti‑hemp coalitions every day. If hemp businesses and consumers do not speak up, repeal and moratorium proposals will be drowned out by calls for stricter bans.
That is why Green Financial built Green Advocacy as a simple, free platform for direct outreach to lawmakers.
Use the tool to send targeted messages supporting full repeal of Section 781 or, at minimum, a multi‑year moratorium instead of a rushed ban.
Choose scripts tailored for email, phone calls, and social posts, and customize them with your own business details, job numbers, and local impact.
Spread the word with suppliers, customers, and other industry partners so they can add their voice and help build bipartisan momentum behind pro‑hemp solutions.
For hemp businesses, the call to action is clear: understand the three bills, decide what outcome you want, and use your voice, individually and through tools like Green Advocacy, to push Congress toward a future where hemp can survive and thrive.
